Protein Engineering of Penicillin Acylase by Tishkov, V.I. et al.
REVIEWS
 VOL. 2  № 3 (6)  2010  | ACTA NATURAE | 47
INTRODUCTION.
Penicillin acylase (PA, EC 3.5.1.11) was discovered 60 
years ago as a catalyst of the hydrolysis of the amide 
bond in penicillin antibiotics [1]. This enzyme belongs 
to the class of hydrolases, a subclass of aminohydro-
lases, and represents a group of so-called N-terminal 
nucleophilic hydrolases. PA has been found in bacteria, 
yeast, and fungi. The physiological role of the enzyme 
remains poorly understood. It seems possible that its 
main function is in utilizing heterocyclic compounds as 
a source of carbon. 
PA has been extensively studied for more than 50 
years. In practice, this enzyme is commonly used to 
produce 6-aminopenicillanic acid, which is the main 
synthon in the synthesis of penicillin antibiotics. PA is 
also used for the synthesis of various semi-synthetic 
β-lactam antibiotics. Broad substrate specificity and 
high regio-, chemo- and stereoselectivity of the en-
zyme are used for the production of chiral compounds 
(which are more and more in demand in modern phar-
maceutics), as well as for the protection of hydroxy 
and amino groups in peptide and fine organic synthe-
sis. 
Currently, the most commonly used PA is that from 
Escherichia coli (EcPA). This enzyme has been bet-
ter studied and characterized in comparison with the 
other PAs; however, the efficiency of the acyl trans-
fer into β-lactam cores, catalysed by EcPA, is not high 
enough to make the enzyme competitive as compared 
with the out-of-date methods of antibiotic synthesis. 
At the same time, intensive spreading of pathogens re-
sistant to currently available antibiotics has inevitably 
prompted the search for new antimicrobial compounds 
with artificial side chains. The catalytic efficiency of 
wild type PA would be too low for the synthesis of 
these substances: therefore, preparation of new mutant 
enzymes with improved synthetic parameters with ar-
tificial substrates is of great importance for practical 
and fundamental science. Another, equally important 
problem is improving a PA’s stereoselectivity in reac-
tions of amino-alcohols acylation and hydrolysis of N-
acyl derivatives, since a PA’s stereoselectivity in re-
actions of amino-alcohols production is incomparably 
lower than for amino acids. 
New enzymes with improved properties can be ob-
tained by various means: for example, random mu-
tagenesis (directed evolution, gene shuffling, etc.) 
and site-directed mutagenesis based on an analysis 
of 3D protein structures (rational design). The sec -
ond approach has become more widespread; howev-
er, it requires knowledge of the enzyme’s 3D struc-
ture, which can be obtained in an experiment (X-ray 
diffraction, NMR) or by computer modeling. In the 
present review we will discuss the recent achieve -
ments in the production of recombinants PAs with 
improved properties. 
CLASSIFICATION OF PENICILLIN ACYLASES
Penicillin acylases represent a group of β-lactam acy-
lases and can be classified according to the type of 
the hydrolysed substrate. Therefore, enzymes can be 
grouped as those that hydrolyse penicillin G, penicillin 
V, or ampicillin. In 1963 it was suggested to divide peni-
cillin acylases into classes I and II [2]. Class I enzymes 
basically hydolyse penicillin V (phenoximethylpenicil-
lin), while class II enzymes use penicillin G (benzylpeni-
cillin) as a substrate. Later, the class III, including the 
enzymes which hydrolyse ampicillin, was added [3-6].
Protein Engineering of Penicillin Acylase
V. I. Tishkov1,2,3*, S. S. Savin2,3, A. S. Yasnaya2,4
1Department of Chemical Enzymology, Faculty of Chemistry, Lomonosov Moscow State University
2Bach Institute of Biochemistry, Russian Academy of Sciences 
3Innovations and High Technologies MSU Ltd. 
4 National Research Center “Kurchatovskii Institute”
*E-mail: vitishkov@gmail.com
Received 05.09.2010
ABSTRACT Penicillin acylases (PA) are widely used for the production of semi-synthetic β-lactam antibiotics and chiral 
compounds. In this review, the latest achievements in the production of recombinant enzymes are discussed, as well as 
the results of PA type G protein engineering.
KEYWORDS penicillin acylase, E.coli, expression, structure, protein engineering
ABBREVIATIONS PA – penicillin acylase, EcPA and AfPA – penicillin acylases from Escherichia coli and Alcaligenes fae�
calis, respectively, 6-APA – 6-aminopenicillanic acid, D-PGA – D-phenylglycine amide, FAA – phenylacetic acid.
Copyright © 2010 Park-media, Ltd. This is an open access article distributed under the Creative  
Commons Attribution License,which permits unrestricted use, distribution, and reproduction in any 
medium, provided the original work is properly cited.48 | ACTA NATURAE |  VOL. 2  № 3 (6)  2010
REVIEWS
An up-to-date classification of acylases of β-lactams 
according to the preferred substrate core structure and 
side chains [7] is shown in Fig. 1. According to this clas-
sification, class II PAs can be additionally divided into 
two subgroups: class IIa – enzymes that basically hy-
drolyse aromatic amides, and class IIb – enzymes that 
hydrolyse aliphatic amides [7,8].
SOURCES AND LOCALIZATION OF PENICILLIN ACYLASES
The activity of penicillin acylase was described for the 
first time by Japanese scientists in 1950 [1]. They found 
that the mycelium of both Penicillium chrysogenum 
and Aspergillus oryzae was able to convert benzylpen-
icillin into phenylacetic acid and another compound, 
which the authors called “penicin” and which was later 
identified as 6-aminopenicillanic acid (6-APA) [1,9,10]. 
More detailed studies of this enzyme were carried out 
in the 1960s. At the time, a large number of papers on 
the enzyme properties, and its potential application, 
were published. Today, the amount of papers devoted 
to penicillin acylases increases with every year.
It should be noted that penicillin acylase activity 
was also detected in bacteria, yeast, and fungi [11-14]. 
At the present time, PAs from more than 40 different 
microorganisms have been described. Many genes of 
penicillin acylases were found in annotated genomes of 
microorganisms. 
Depending on the species of the microorganism, 
the enzyme can dwell either outside or inside the cell. 
Localization in periplasma is chrachteristic for active 
forms of G-class penicillin acylases (class II). Extracel-
lular expression is also typical for some strains produc-
ing penicillin acylases V (class I) and penicillin acylases 
G (class II). The physiological role of PAs remains un-
clear despite a 60-year-long history of studying them. 
It is highly probable that PAs are needed for the utili-
zation of aromatic amides as carbon sources [15]. Basic 
properties of some well-studied penicillin acylases are 
presented in Table 1.
CHARACTERISTIC FEATURES OF PENICILLIN 
ACYLASE G EXPRESSION
PA-G gene encodes a precursor polypeptide which 
consists of 4 structural elements: a signal peptide, α- 
and β-subunits, and an inter-subunit spacer. The ma-
ture PA-G molecule is a heterodimer with a molecular 
weight of 86 kDa. It consists of two subunits, α- and β-, 
with molecular masses of 23 and 63 kDa, respectively 
[23,24]. In addition, the molecule contains a bound Ca2+ 
ion, which, according to data, is important for enzyme 
processing [18]. 
Posttranslational modification of PA-G is a multi-
stage process, which has been well studied for the en-
zyme from E.coli. The first step includes transport of 
the inactive precursor from the cytoplasm to the peri-
plasmic compartment, a process drived by the signal 
peptide, which is then removed after the transport is 
completed. Afterwards, the inter-subunit spacer un-
dergoes two-step proteolysis, which results in the for-
mation of an active heterodimer [23,25,26]. 
In E.coli cells, transport of most of the proteins 
across the membrane is mediated by Sec-translocase. 
Sec-system recognizes signal peptides that do not have 
similar sequences but are quite close in their physico-
β-Lactam acylases
Penicillins Cephalosporins
Penicillin G
Phenylacetyl
Класс I II III IV
Phenoxyacetyl α-Aminoacyl δ-Aminoadipyl Glutaryl
Penicillin V Ampicillin Cephalosporin C Glutaryl 7-ACA
α-Acylamino-β-lactam acylhydrolases
Fig. 1. Modern 
classification 
of β-lactam 
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of substrate 
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chemical properties. SecB-chaperone recognizes a short 
sequence containing aromatic and positively charged 
amino acids, which subsequently is processed by Sec-
translocase [27]. SecB is a basic component that partici-
pates in the translocation of many secretory and peri-
plasmic proteins. In work [28], it was shown that SecB 
is essential for EcPA-G maturation. 
Another pathway of protein secretion is the Tat-sys-
tem (twin arginine translocation). This mechanism is 
considered to mediate the transport of folded proteins 
with bound cofactors across the membrane. Evidently, 
the Tat-system and Sec-system work independently. 
In Tat-mediated transport, it is necessary for the sig-
nal peptide sequence to include the SRRXFLK motif, 
which contains two arginine residues [29]. The sequence 
of the signal peptide in the EcPA precursor contains 2 
arginines separated by an asparagine residue (Fig. 2). 
Some literature data indicate that such a signal peptide 
can provide Tat-mediated enzyme processing. More re-
cent data directly show that the E.coli signal peptide 
accounts for the enzyme translocation by the Tat-sys-
tem [30]. PA from Alcaligenes faecalis is transported via 
the Sec-system [31].
Experiments on PA protein precursors lacking the 
signal peptide show that the inter-subunit spacer is 
initially cleaved at the N-terminus of the β-subunit, 
which, as a result, yields a free  β-subunit and a 
polypeptide consisting of the α-subunit and the spacer 
[23]. Spacer cleavage occurs similarly in two stages in 
the course of PA maturation in an intracellular medi-
um [23]. The authors of [23] demonstrated that spacer 
cleavage from the N-terminus of the β-subunit could 
take place only in the periplasmic compartment, while 
spacer removal from the C-terminus of the α-subunit 
can also take place in cytoplasm. At the same time, 
work [26] revealed that, at the very beginning, the 
α-subunit acquires a folded structure before begin-
ning to function as a template for the correct folding of 
the β-subunit. Later, it was shown that spacer cleav-
age is an autocatalytic process [25]. Amino acid resi-
dues Lys299 and Thr263 of the inactive precursor were 
shown to play the primary role in the correct folding of 
the enzyme. Amino acid substitutions in these positions 
lead to a decreased yield of the active enzyme and ac-
cumulation of the inactive precursor [25, 32].
In summing up the available data, it is important to 
note that all stages of PA-G processing play an impor-
tant role in the production of an active and soluble pro-
tein. The introduction of amino acid substitutions can 
affect any steps in protein processing; therefore, the 
production of active forms of novel mutant enzymes 
requires a careful selection of appropriate conditions 
for cultivation.
EXPRESSION OF RECOMBINANT PAs iN E.coli
Depending on the purposes being pursued, cloning and 
expression of recombinant enzymes can be performed 
in various systems; for example, bacteria [33-36], yeast 
[37-40], plants [41-43], insect cells [44-47], or cell-free 
systems [48-51]. Since PA-G is found only in bacteria, 
E.coli-based expression systems are considered to be 
the most appropriate for recombinant enzyme produc-
tion. Below, we will discuss various approaches of PA-G 
expression in E.coli cells.
Table 1. Main characteristics of penicillin acylases from different sources
Class Source Preferable substrate* Induction  
of biosynthesis
Cell  
localization References
Class I
PA-V
Streptomyces lavendulae Pen-V, Pen-K no outside [3]
Dermatophytes Pen-V yes inside [3]
Penicillium chrysogenum Pen-V, Pen-K yes inside [3]
Bacillus sphaericus Pen-V no data outside [16]
Fusarium sp. Pen-V no data outside [17]
Class II
PA-G
E. coli Pen-G, Pen-X yes inside [18]
Bacillus megaterium Pen-G, Cephalexin, 
Cephaloglycine, Cephaloridine no data outside [19]
Alcaligenes faecalis Pen-G no data inside [20]
Providencia rettgeri Pen-G no data inside [21]
Class III 
Amp-PA Pseudomonas melanogenum Amp, Cephaloglycine, Cephadrine, 
Cephalexin no data inside [22]
* Amp – ampicillin, Pen-G – penicillin G, Pen-V - penicillin V, Pen-K – penicillin K, Pen-X – penicillin X50 | ACTA NATURAE |  VOL. 2  № 3 (6)  2010
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Selection of promoter and expression vector
A substantial amount of information on homo- and het-
erological PA expression in E.coli can be found in the 
literature. In terms of choosing an expression vector, 
both high- and low-copy number plasmids have been 
used. The following promoters have been applied for 
control of protein expression: lac, tac, trc, T7 and araB. 
PA-G genes were cloned from E. coli [52, 53], Actino�
myces viscosus [54], Providencia rettgeri [55], Kluyvera 
citrophila [56], Bacillus megaterium [35, 57], and A. fa� . fa� fa�
ecalis [20]. The influence of the promoter type on the 
PA yield is shown in Table 2. There is no strong cor-
relation between the type of promoter and the yield of 
the active enzyme. As a rule, stronger promoters (e.g. 
promoter of a T7 phage RNA-polymerase) provided   
higher levels of expression; however, in many cases it 
Table 2. Cultivation conditions and their influence on yields of recombinant PA’s 
Enzyme 
source
Producing 
strain
Promo-
ter
Antibiotics 
resistance Inductor Т, °С Medium Additives Enzyme yield Reference
Orga-
nism Strain
E. coli
E. coli JM109 trc IPTG/
arabinose 30 LB 112 U/L/А600, 
193 U/L/А600
[66]
E. coli
JM109 
BL21 
HB101
Т7 Kn arabinose 30 LB glycerol
330  U/L /А600,  
820 U/L ,
440 U/L /А600,
690 U/L
[63]
E. coli GM48
HB101
T7 
Trc Kn IPTG 30 LB 84 U/L /А600 [32]
E. coli MC1000 lacZ Kn IPTG 28 M9 PAA 14–650 U/g [67]
E. coli DH5α tac 
lacI CmR IPTG [68]
E. coli x6212 trc IPTG 1000 U/L , 
700 U/g [69]
E. coli
JM101, 
JM103, 
JM105
lac Kn IPTG
galactose М9
glucose, 
galactose, 
glucose+ 
galactose
20–800 U/L [70]
E. coli SecB-
chaperone 40–126 U/L/А600 [28]
E. coli Cm IPTG 28 М9 Ca2+ 1 g/L  
1700 U/g [31]
E. coli
trc 
T7 
araB
Kn 
Cm
IPTG, 
arabinose
degP-
chaperone
PA: 20-800 U/L  
PA: 10450 U/L [65]
E. coli BL21 
(DE3) T7 [60, 71]
E. coli
HB101, 
JM109, 
MC4100
araB
Cm 
Kn 
Amp
degP-
chaperone
14–470 U/L,  
570 U/L /А600
[60]
A. faeca�  faeca� faeca�
lis
E. coli Cm IPTG М9 Ca2+ 2.3 g/L , 14000  
U/g (AfPА) [31]
E. coli HB101 1000 U, 23 mg/L [20]
E. coli JM109 rhaBAD Amp rhamnose M9 
LB
glucose, 
proline
4500 U/L ,  
0.96 U/mg [72]
E. coli JM109 
(DE3) T7 Kn IPTG LB (200–270)×103 
U/L [21]
K.  
citrophila E. coli BL21 
(DE3) T7 Kn IPTG
YE 
TH 
M9 
MR
13460 U/L 
1190 U/L /А600  
28056 U/L   
1576 U/L /А600
[60]REVIEWS
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leads to abnormal protein folding and accumulation of 
an insoluble enzyme as the so-called inclusion bodies. 
The yield of the soluble protein can be increased by 
using less strong promoters. Generally, expression of 
each individual enzyme requires selecting an optimal 
vector.
Factors that affect the level of PA expression are 
transcription and translation [53]. The limiting stage 
depends on the selected vector and the host strain. Nev-
ertheless, most researchers choose strong promoters, 
such as tac and T7, and isopropyl-β-D-thiogalactoside 
(IPTG) is used as inducer. The yield of the soluble na-
tive protein is usually increased through the optimiza-
tion of cultivation parameters. 
Influence of the temperature
Work [58] revealed that the yield of active PA strongly 
depends on the temperature of cultivation. The experi-
ments on protein expression were carried out at three 
different temperatures: 22, 28, and 37oC. For all combi-
nations of plasmids and host strains, the highest yield 
of the native protein was observed at 22°С. This effect 
is probably explained by the fact that, at a low temper-
ature, the enzyme undergoes successfully all stages of 
posttranslational modification and acquires the native 
conformation, which leads to an increase in the yield 
of the soluble active enzyme. An increase in tempera-
ture causes an increase in the rate of protein synthesis; 
therefore, the insoluble enzyme is accumulated in the 
cytoplasm.
Influence of the medium composition and various ad-
ditives
Numerous studies have shown that the composition 
of the cultivation medium strongly affects the level of 
expression and the yield of the active enzyme. Work 
[59] showed that the highest yield of active PA-G is 
achieved when the minimal medium M9 is used with 
glucose as a carbon source. This approach allows to in-
crease the portion of the periplasmic enzyme nearly 
100-fold, relative to the intracellular enzyme. High en-
zyme yields were also achieved using the richest me-
dium, YE, of all those studied (YE, TH, MR, M9), as de-
scribed in [60]. 
One of the key parameters of PA expression is the 
presence of calcium ions in the cultivation medium. 
Ca2+ is important both for cellular growth [61] and for 
the formation of active soluble PA, since calcium ions 
are present in molecules of active PA [24,60]. Accord-
ing to some authors, Ca2+ plays an important role in the 
translocation of the protein precursor across the mem-
brane, as well as in the correct folding and maturation 
of the enzyme in the periplasm [31].
Another approach that allows to increase the level of 
soluble PPA in the cell is adding low-molecular carbon 
sources into the medium. It has been shown that ad-
ditional carbon sources allow to increase the biomass, 
as well as diminish the accumulation of the insoluble 
protein in the cell [62]. The most common low-molecu-
lar carbon-containing compounds are lactose, glucose, 
arabinose, and glycerol. Works [62,63] showed that the 
addition of glycerol reduces the level of the insoluble 
protein in the periplasm. Some authors consider glyc-
erol as not only a carbon source, but also a “chemical 
chaperone” that facilitates protein folding and matu-
ration. 
Regulation of the posttranslational modification
Work [59] focuses on selecting the optimal strain for 
expression and optimization of medium compositions, 
as well as modifying the PA translocation system by 
means of alteration of the signal peptides structure. As 
it was previously discussed, the signal peptide of EcPA 
is responsible for the translocation of the precursor by 
the Tat-system [31]. However, as is known from the 
literature, Sec-mediated protein transfer occurs more 
rapidly [64]. The alteration of the translocating system 
allowed a substantial increase in the level of the soluble 
protein in the periplasmic fraction.
The use of chaperons for correct PA folding 
An additional, actively developing approach that has 
emerged over the past decade is the use of chaperones 
for the optimization of protein expression. In case of PA, 
most researchers used degP chaperones or the chaper-
ones of the Sec-system, if they participate in the in-
tracellular transport of the enzyme [65]. This approach 
helps to achieve a many-fold increase in the yield of the 
active enzyme. 
In summary, it should be noted that PA-G expres-
sion depends on numerous factors. To create a strain for 
PA overexpression, one should be well aware of the de-
tails of limiting stages of expression, which are specific 
for each organism and expression system. The yield 
of the active enzyme can be improved if proteinases-
lacking strains or strains with an altered translocation 
system are used. 
PA-G STRUCTURE
Primary structure of PA-G
At present, databases (GeneBank, EMBL) contain full 
nucleotide and amino acid sequences of PA-Gs from 
40 organisms. Figure 2 shows the alignment of amino 
acid sequences of PA-Gs from different sources. In or-
der to show comparison, the most distant enzymes are 
presented. The primary structure of E.coli PA is given 
as a full-length amino acid sequence, whereas for the REVIEWS
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other enzymes only the differing residues are shown. 
Well-conserved residues are marked by dark gray, 
and similar residues are given in light gray.
As is seen in the figure, the signal peptide region 
contains no conserved residues or consensus sequences. 
They all differ not only in the amino acid sequence but 
also in length. Intra-subunit spacers differ as well and 
do not have conserved amino acids in their sequences.
The sequences shown in Fig. 2 contain two impor-
tant conserved amino acid motifs: (D/E)RXXQ(M/L)
(E/D) in the α-subunit and NXXYADXXGNI(G/A)Y 
in the β-subunit. Apart from these two regions, there 
are some well-conserved residues, e.g., first and second 
residues in the β-subunit are serine, which is impor-
tant for catalysis and neighborous asparagine. The total 
amount of highly conserved residues in PA- sequences 
does not exceed 7%. 
Figure 3 shows the phylogenetic tree of PA-Gs. As is 
seen, most of these enzymes occur in proteobacteria. 
Quaternary structure of PA-G.
The first 3D structure of the PA-G molecule was de-
termined in 1995 for a PA from E. coli with a resolution 
of 1.9 Å (PDB 1PNK) [24] (Fig. 4). The active enzyme 
is a heterodimer with a molecular mass of 86 kDa. It 
consists of a smaller α-subunit (24 kDa) and a bigger 
β-subunit (62 kDa). At the N-terminus of the β-subunit, 
there is the Ser catalytic residue (marked red in Fig. 4). 
The average dimensions of the heterodimer are 70 x 50 
x 55 Å. The polypeptide chains of the two subunits form 
a pyramid-like structure with a deep bowl-like cavity in 
the middle, with the active site located on its bottom. 
Like all Ntn-hydrolases, PA-G contains the charac-
teristic motif αββα [73]. PA has one αββα - domain which 
consists of α- and β-subunits [24], and the domain is one 
of the biggest αββα ones among all known Ntn-hydro-
lases [73]. 
In terms of the structure, the protein globule can 
be divided into three regions - A, B, and C. Region C 
includes eight elements of a secondary structure con-
served in all representatives of Ntn-hydrolases. These 
elements form three antiparallel layers of four αββα�
motifs, each. Regions A and B consist of similar elements 
of a secondary structure whose spatial arrangement is 
quite the same in all representatives of Ntn-hydrolases. 
However, these regions might occupy different posi-
tions in polypeptide chains of various Ntn-hydrolases. 
For example, in the PA-G molecule, regions A, B, and C 
are arranged in the following order: C-B-A. 
0.1
         H. marismortui
         P. denitrificans
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           S. wittichii
            S. proteamaculans
        A. xylosoxidans
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                      C. aggregans
                       N. punctiforme
                       B. weihenstephanensis
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                       B. cereus
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Fig. 3. Phylogenetic tree of penicillin acylases G.
Fig. 4. Structure of the active heterodimer of PA-G from 
E.coli (PDB 1PNK) [24]. α- and β-subunits are shown 
in yellow and dark blue, respectively. Catalytic βSer1 
residue and Ca2+ ion are shown in red and green, respec-
tively.54 | ACTA NATURAE |  VOL. 2  № 3 (6)  2010
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At the end of 2009, the 3D structure of recombi -
nant PA from A. faecalis (AfPA) expressed in E.coli 
cells was deposited into the protein data bank (PDB), 
although this enzyme was isolated and described ear-
ly in the 1990s. In May 2010, the second structure of 
AfPA obtained from orthorhombic crystals appeared 
in the PDB (PDB 3ML0). AfPA is of particular interest 
due to high thermal stability compared to one for all 
known penicillin acylases G. An analysis of the AfPA 
structure revealed that the elevated thermal stabil-
ity is associated with the presence of a disulfide bond 
between Cys492 and Cys525 in the β-subunit (marked 
pink in Fig. 5), which are absent in EcPA. The struc-
tures of AfPA and EcPA share a high spatial homol-
ogy. A computer superposition of the structures of 
these two enzymes shows high spatial homology in the 
organization of their polypeptide chains, especially in 
the region of the active site. Some minor deviations are 
observed only in the outer regions of the enzyme mol-
ecule. It should be noted that both  AfPA structures 
have a resolution only of 3.3 and 3.5 Å for PDB3K3W.
ENT and PDB3ML0.ENT, respectively. This resolution 
is considered low in modern X-ray crystallography 
and does not allow to determine exactly the spatial 
arrangement and interactions of residues in the active 
site, which is important for understanding catalytic 
mechanism.
STRUCTURE OF EcPA’s ACTIVE SITE
Structure of the catalytic domain
The early studies of PA revealed the key role played by 
a Ser residue in catalysis. Covalent modification of this 
residue by phenylmethylsulfonylfluoride (PMSF) was 
shown to lead to the full loss of the enzyme activity [74]. 
X-ray diffraction data on PA covalently modified with 
PMSF (PDB 1PNM) [18] allowed to determine that the 
catalytically important residue is the N-terminal serine 
of the β-chain. It is worth noting that in the vicinity of 
βSer1 there are no imidazole or carboxyl groups that 
participate in the catalytic processes of acylation and 
deacylation by means of relay proton transfer and are 
usually found in active sites of serine proteases. There-
fore, PAs were classified as so-called hydrolases with 
the N-terminal nucleophile, or Ntn-class [75].
Based on the structural data obtained on EcPA, a 
model of the catalytic mechanism of Ntn-hydrolases 
was proposed in 1995. N-terminal serine βSer1 functions 
as a nucleophile (marked red in Fig. 6). Residue βGln23 
(shown in red in Fig. 6), which is positioned close to 
βSer1, improves the nucleophilic properties of the cata-
lytic serine. During the reaction, the covalent intermedi-
ate is formed trough a transition state, which is stabi-
lized by a so-called oxianionic hole. The hole is formed by 
residues βAsn242 and βAla69 (marked pink in Fig. 6).
Fig. 5. Structure of the active heterodimer of PA-G from 
A .faecalis (PDB 3K3W). α- and β-subunits are shown in 
yellow and dark blue, respectively. Catalytic βSer1 resi-
due and Ca2+ ion are shown in red and green, respective-
ly. Disulfide bond in β-subunit between residues Cys492 
and Cys525 in wild-type enzyme is shown in magenta. 
Insert in right part of figure shows fixation of N-terminus of 
α-subunit and C-terminus of β-subunit due to creation of 
new disulfide bond (shown in orange) after double muta-
tion αQ3C/βP751C.
Fig. 6. Main amino acid residues in the active site of PA 
from E. coli (structure PDB 1AI4). Catalytic βSer1 resi-
due and residue βGln23 are shown in red and orange, 
respectively. Residues from oxyanion hole are presented 
in magenta.  Residues from substrate-binding domain are 
shown in green and yellow for subdomains S1 and S2, 
respectively. Residue αPhe146 belonging to both subdo-
mains is in blue.REVIEWS
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A comparison of the amino acid sequences of PA-
Gs from different sources (Fig. 3) reveals that residue 
βAsn242 is highly conserved in all mentioned enzymes, 
while residue βAla69 occurs only in the half sequences 
presented and Asp residue is present in this position in 
other enzymes.
Structure of the substrate-binding domain
The substrate-binding domain of the active site con-
sists of two subdomains – S1 and S2. Subdomain S1 is 
responsible for interacting with the acyle part of the 
substrate. It exhibits high binding specificity and con-
sists basically of hydrophobic residues. The “closed” 
structure of this domain, as well as its high hydropho-
bicity, makes the enzyme very selective for benzene 
rings with small radicals at Cα-atoms or aromatic rings. 
The main residues which form the “closed” structure 
of the S1 subdomain are αMet142, αPhe146, βPhe24, 
βPhe57, βTrp154, βIle177, and βSer67 (marked green 
in Fig. 6) and also  βPro22, βGln23, βVal56, βThr68, 
βPhe71, βLeu253, and βPhe256 (not shown in Fig. 6). As 
is seen, only two residues are located in the α-subunit, 
while most of the residues that are essential for binding 
the acyl part of substrate are located in the β-subunit. 
The sterically limited hydrophobic cavity in the “open” 
state has a thermodynamically unfavorable contact 
with the solvent. Hydrophobic interactions between 
the substrate and the enzyme result in a double energy 
gain due to, first, the energy of transfer of a hydropho-
bic substrate into the enzyme hydrophobic cavity from 
the solvent and, second, due to the exclusion of water 
molecules from the active site. 
It is suggested that π-π interactions exist between 
the benzene rings of the phenylacetic acid (PAC) 
and βPhe24, which are located side by side. Residue 
αPhe146 is located at the opposite side of the hydro-
phobic pocket. It interacts with PAC and shields the 
active site from the solvent. Another phenylalanine 
residue, βPhe57, is located at the bottom of the hy-
drophobic cavity. The shortest distance between this 
residue and the inhibitor is 4.7 Å, which is insufficient 
for a direct interaction. However, this residue may be 
essential for the proper overall structure maintenance 
of the substrate-binding site, since it is located close 
to βPro22 and βPhe24 (the distances are 3.5 and 3.9 Å, 
respectively), which directly participate in substrate 
binding.
The second subdomain of the substrate-binding site 
(S2) is responsible for the binding of the nucleophilic 
part. This subdomain represents the bottom of the 
bowl-like cavity in the middle of the molecule and ac-
counts for the enzyme’s quite broad specificity for the 
nucleophilic part. Besides, this domain is enantioselec-
tive, which allows to use the enzyme for kinetic separa-
tion of the optical isomers of amines. Domain S2 consists 
of the following residues: αArg145, αPhe146, βPhe71, 
and βArg263 (marked yellow in Fig. 6) [76-80].
According to the analysis of the structure of the 
EcPA inactive mutant βAsn241Ala complex with peni-
cillin [79], at the first stage the antibiotic binds in the 
“open” conformation, which allows the bulky amide 
part of the substrate to enter the enzyme’s active site. 
In the “open” conformation the βPhe71 phenol ring be-
comes parallel to the substrate’s β-lactam ring. More-
over, substrate sorbtion results in Van-der-Waals 
interactions between the methyl group of the peni-
cillin molecule and Сδ1-atoms of αPhe146, which also 
strengthens the bond.
A complex of the native enzyme with a “slow” sub-
strate penicillin G sulfoxide (PDB 1PNM) gives informa-
tion about the enzyme’s structure in pre-catalytic act 
stage [78]. In this case, the positions of residues αArg145 
and αPhe146 correspond to the “closed” conformation, 
and the amide group of βAsn241 forms a hydrogen bond 
with O-atom of the substrate’s carbonyl group.
Results of site-directed mutagenesis of residues 
αArg145 and βArg263 show that both of them are es-
sential for catalysis and βArg263 is also essential for 
autocatalytic maturation [77]. Structural and kinetic 
data indicate that βArg263 participates in the stabili-
zation of the transition state, since its positive charge 
increases the polarity of the oxianionic hole. It should 
be noted that both βArg263 and αArg145 are  highly 
conserved and present in PA-Gs of nearly all known 
sources (see Fig. 2).
Another special feature of PA catalytic mechanism 
is that the active site can exist in “open” and “closed” 
conformations, as was shown in [80]. The authors re-
solved the structure of complexes of EcPA with various 
ligands. The “open” conformation is important for sub-
strate binding, while effective catalysis requires pro-
tection of the active site from solvent molecules, which 
is achieved in the “closed conformation.”
PA-G PROTEIN ENGINEERING
In the past, the main approach to increasing the ef-
ficiency of industrial processes had been to optimize 
conditions in the biocatalytic process. Such optimiza-
tion was based on kinetic parameters and the physico-
chemical properties of the reaction medium’s compo-
nents. This approach was successful and led to some 
very good results. Today, the approach has practically 
exhausted its potential: actual design of the enzyme is 
becoming increasingly popular.
X-ray diffraction studies on PA, its mutants, and 
complexes with different substrates have provided a 
prospective for understanding the structure-function 
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site. The purpose of this design is to improve the en-
zyme’s properties, which could increase the efficiency 
of PA-mediated synthesis of antibiotics and separation 
of enantiomers. 
Because of thermodynamic constraints, the synthesis 
of antibiotics is based not on direct condensation but on 
nucleophilic substitution. The minimal scheme of the 
process is given below:
Scheme 1. A minimal scheme for half-synthetic β-lactam 
antibiotics preparation by nucleophilic substitution. E, S, 
and ES are the enzyme, substrate (donor of acyl moiety), 
and the enzyme-substrate complex, respectively. EA, 
Nu, and EANu are the acyl-enzyme, nucleophile, and 
the double complex of acyl and nucleophile. Ks, Kn, and 
Kp - are binding constants of substrate free enzyme E, the 
nucleophile with acyl-enzyme EA, and the product with 
free enzyme E, respectively.
Papers [81, 82] contain a detailed analysis of this 
scheme and its various derivatives. The basic result 
following from this analysis is that the description of 
the process’s efficiency cannot be accomplished by us-
ing such common parameters as catalytic constants, 
Michaelis constants, or constants of inhibition by the 
reaction products. The parameters α, β, and γ are used 
instead. Parameter α = (k-4/Kp)/(k2/Ks) describes the 
specificity of the enzyme for the product and initial 
acyl donor, parameter β = k4/(k3·Kn) reflects the maxi-
mum nucleophilic activity of acceptor, and γ = k5/k4 
describes the ability of the triple complex EANu to 
undergo either synthetic or hydrolytic transformation 
(i.e., the ratio of the rates of synthesis and hydrolysis, 
S/H). Therefore, we shall use the above-mentioned 
parameters in estimations of the efficiency of PA engi-
neering and in studies of PA mutant forms, as applied 
to antibiotic synthesis. 
Production of chimeric PAs by means of DNA shuf-
fling
At present protein engineering exploits a broad range of 
approaches based on the introduction of both directed 
and random amino acid substitutions, or even fragments 
of a polypeptide chain. One of these approaches, namely 
DNA shuffling, is now increasingly gaining in popularity 
and is successfully applied in the production of industri-
ally significant enzymes with enhanced properties. This 
method is based on a recombination of genes coding for 
homological enzymes from various organisms, which re-
sults in the production of chimeric proteins that consist 
of fragments of original enzymes. 
DNA shuffling has been applied in engineering PAs 
from E. coli, K. cryocrescens, and P. rettgeri [83]. The 
extent of homology of these enzymes is equal to 77% 
(E. coli – K. cryocrescens), 61% (E. coli – P. rettgeri), 
and 61% (K. cryocrescens – P. rettgeri). Screening of 81 
transformants revealed three chimeric enzymes that 
exhibited higher catalytic activity (vPs) as well as im-
proved synthetic properties (see Table 3).
It is noteworthy that in enzyme 6B11 all parameters 
were selectively improved. It was shown in an experiment 
that a decrease in α was caused by a two-fold increase in 
KP for ampicillin (the product), while in 73С4 an increase 
in α was caused by a two-fold increase in K s for D-PGA.
DNA sequencing showed that chimeric mutants 
6B11 and 73С4 were obtained by inclusion of some 
parts of the PA gene from K. cryocrescens into that 
of E.coli. A certain number of random mutations that 
do not occur in the parent genomes and are located 
far from the active site were also described. However, 
these mutations can have a substantial effect on the 
enzyme’s properties. For example, the substitution of 
βGly385, which is positioned 13.5 Å from the active site, 
by serine residue (βGly385Ser) in the hybrid 6G8 can 
affect the availability of the active site. To study the 
influence of such substitution on the catalytic proper-
ties of enzyme, the authors introduced the correspond-
ing mutation into EcPA. The results were amazingly 
unpredictable: the authors reported a 22% increase in 
the maximum yield and a 80% increase in the S/H ra-
tio compared to the wild type enzyme under the same 
conditions. The parameter α did not change. Similarly, 
random mutation of αAsp148Gly works in the same 
way, i.e. it results in a 20% increase in the maximum 
yield and an 80% increase in the S/H ratio. In the case 
of this amino acid change the observed effect can be 
Table 3. Synthetic efficiency of parent and hybrid PA (15 
mM D-PGA, 25 mM 6-APC, рН 7.0)
Enzyme α β, 
мМ-1 γ Pmax, 
mM vPs %
PA E. coli 7.8 78 0.14 2.2 100
PA K.cryocrescens 12.7 98 0.19 2.1 110
PA P.rettgeri 5.8 32 0.30 1.9 59
PA 6G8 11.1 130 0.12 2.6 149
PA 73C4 11.6 120 0.12 2.4 95
PA 6B11 6.4 115 0.13 2.5 115REVIEWS
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explained by the fact that the αAsp148 is located at the 
base of the catalytic α-loop, which is responsible for the 
conformational transitions in the active site. As it was 
shown for residues αArg145 and αPhe146, any changes 
in this loop can lead to the alteration of both the sub-
strate specificity and catalytic activity.
Thus, DNA shuffling can be employed not only as a 
tool in the production of enhanced versions of PA, but 
also as a promising approach to the design of site-di-
rected mutations that are impossible to predict based 
on knowledge of the enzyme’s 3D structure.
Combinatory saturating mutagenesis
In work [84], saturating mutagenesis was combined 
with the introduction of random mutations and applied 
to residues αR160, αF161, and βF24, which were jux-
taposed to the enzyme’s active site (single, double, as 
well as triple mutants were obtained). Different amino 
acid changes were introduced in these positions with 
degenerate primers, and a library of 700 various clones 
was obtained. HPLC-based screening was used to test 
mutants for their ampicillin synthetic activity. As a re-
sult, three mutants with improved catalytic properties 
were selected (Table 4). Moreover, one of the mutants 
(βF24A) also exhibited good catalytic properties in the 
reaction of cefalexin synthesis.
It should be noted that the method of random muta-
genesis has not found broad application, because of the 
absence of a simple mutant screening procedure. At the 
same time, directed mutagenesis has turned out to be 
the most popular method.
RATIONALE DESIGN
Acyl-binding domain
Processes of preparation of β-lactam cores by hydro-
lysis of natural antibiotics will be more efficient in the 
case of reduced affinity of the enzyme to phenylacetic 
acid, which is a byproduct of the reaction and a com-
petitive inhibitor of PA. A requirement for effective 
synthesis of half-synthetic unnatural antibiotics is a 
high specificity of the enzyme for the FAA derivatives 
carrying substitutions at Сα atom (D-phenylglycine, 
phenyglycolic acid, Сα-methyl-FAA). In case of natural 
PAs, the values of the Michaelis constants for FAA de-
rivatives carrying substitutions at Сα are about 10-100 
mM, which is 100-1,000 times higher than for FAA [85]. 
Therefore, production of mutant enzymes with low val-
ues of the Michaelis constant for FAA derivatives car-
rying substitutions at the Сα atom and high inhibition 
constants for FAA is of great interest.
Paper [86] describes point mutations  βPhe24Ala 
and αPhe146Tyr and their combination βPhe24Ala/
αPhe146Tyr meeting these requirements. For exam-
ple, in case of mutant EcPA βPhe24Ala, FAA inhibi-
tion was 18 times lower in comparison with the wild-
type enzyme (Kp = 1.1 and 0.06 мМ, respectively), but 
affinity to Сα-substituted FAA derivatives was 5 times 
higher. Constructing the mutants, the authors sug-
gested that substitution of the hydrophobic residue 
that forms the base of the acyl-binding domain could 
dramatically change the enzyme’s specificity for both 
Сα-substituted FAA derivatives and the natural sub-
strate.
X-ray analysis of complexes of the mutants with 
FAA derivatives provided structural explanations of 
the observed phenomena. Removal of the aromatic ring 
in the mutant βF24A leads to structural perturbations 
in the active site. As a result, in this mutant FAA binds 
in the “open” conformation, as opposed to the wild-type 
enzyme in which FAA binds in the “closed” conforma-
tion. This, in its turn, results in the disappearance of 
hydrogen bonds between the carbonyl O-atom in FAA 
and residues βAla69 and βAsn241 that form the oxian-
Table 4. Catalytic efficiency of mutant  EcPA in reactions of antibiotic synthesis [84]
Enzyme Acyl donor
Ampicillin Cephalexin
α β, mM-1 1/γ α β, mM-1 1/γ
PAS2
ФГА 13.2 0.5 6 7.3 0.5 59
ФГМ 16.4 0.5 6 9.1 0.5 59
αR160K 
αF161L 
βF24M
ФГА 218 6.3 364 58.8 18.4 69
ФГМ 8.8 6.3 364 2.4 18.4 69
βF24A
ФГА 209 10.2 286 88.8 21.5 154
ФГМ 11.6 10.2 286 4.9 21.5 154
αR160P 
αF161A 
βF24A
ФГА 200 4.9 167 57.2 21.1 58
ФГМ 7.6 4.9 167 2.2 21.1 5858 | ACTA NATURAE |  VOL. 2  № 3 (6)  2010
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ionic hole. This explains the multi-fold increase in the 
value of the inhibition constant.
Unlike FAA itself, its derivative  Сα-methyl FAA 
binds in the “closed” conformation in the mutant EcPA 
βF24A. Simultaneously, Cα-CH3 takes the place of the 
removed phenyl group, which leads to a 10-fold in-
crease in binding.
Notably, the mutation of βPhe24 strongly affects 
the enzyme stereospecificity for (R)-isomers of Cα-
substituted FAA derivatives. Therefore, βPhe24 can be 
a potential target for alteration of the enzyme enanti-
oselectivity, which can be used for obtaining optically 
pure Cα-substituted FAA derivatives.
Substitution of phenylalanine by tyrosine in the 
αF146Ymutant does not cause conformational rear-
rangements in the active site, which explains the FAA 
binding comparable to that in wild type EcPA. Howev-
er, the van der Waals interactions between a Cα-group 
of FAA derivatives and OH-group of αTyr146 make 
binding more efficient.
In work [87], the natural specificity of EcPA was al-
tered from penicillini to cephalosporin C, which gave 
the opportunity to create a EcPA-based biocatalyst for 
preparation of 7-aminocephalosporinic acid directly 
form cephalosporine C. An alignment of the amino acid 
sequences of EcPA and cephalosporinacylase (CA) from 
P. diminuta was performed in order to determine the 
binding site for the aromatic hydrophobic acyl part of 
penicillin in PA and that for the linear hydrophilic (glu-
taryl) acyl part of cephalosporin C in CA. As a result, 
seven residues from the hydrophobic pocket of EcPA 
were substituted by the corresponding residues from 
CA. The obtained mutant had a specificity for cepha-
losporin C 8-fold higher than wt-EcPA. Unfortunately, 
these results are of little practical use aside from scien-
tific interest, since the activity of the prepared mutant 
enzyme was much lower than that of the native CA. 
Site-directed mutagenesis of the nucleophile-binding 
site
Increasing the acyl part-binding properties is insuf-
ficient for improving the enzyme synthetic efficiency. 
For example, for mutant EcPA βPhe24Ala it was shown 
that increased D-phenylglycinamide binding leads to 
an increase in product (ampicillin) binding, which fi-
nally elevates parameter α. Interestingly, substitutions 
of residues βPhe24 and αPhe146, which are responsible 
for binding the acyl moiety, also account for a two-fold 
increase in the nucleophile properties of 6-APA.
The fact that alterations of the protein structure in a 
particular region can cause structural rearrangements in 
adjacent regions does not contradict the basic principles 
of protein molecule organization. Mutations in the acyl-
binding part (S1) could actually cause structural changes 
Table 5. Kinetic parameters for ampicillin synthesis for 
wild-type enzyme and mutant  EcPA with substitution of 
αArg145 (15mM D-PGA, 25мМ 6-APC, pH 7.0)
Enzyme α β .,мМ-1 γ Pmax, 
mM 
EcPA wild-type 7.7 80 0.14 2.2
EcPA αArg145Gly 29 420 0.04 3.6
EcPA αArg145Ser  14 350 0.05 3.3
EcPA αArg145Leu 15 280 0.06 2.8
in the nucleophile-binding site (S2) so long as residues 
βPhe24 and αPhe146 are located in the border region of 
S1 and S2 subdomains and these residues produce the 
hydrophobic neck of acyl-binding domain (Fig. 6).
On the other hand, it is impossible to determine 
whether the increase in nucleophile binding (K n) or 
decrease in water reactivity (k3, k5) plays the key role. 
βPhe24Ala substitution could affect the spatial posi-
tion of the neighboring βGlu23, which coordinates the 
deacylating water molecule and, therefore, decreases 
the rate of hydrolysis. However, using available data, 
it was shown that improving the enzyme nucleophilic 
specificity causes an increase in  β: so the effects of 
point mutations in the nucleophile-binding site are 
rather predictable. In work [89], the authors achieved 
a substantial increase in parameter β by mutations of 
αArg145, which interacts with the ampicillin carboxylic 
group in the closed conformation and can affect 6-APA 
binding, according to X-ray analysis. In order to study 
all the possible effects of a substitution of  αArg145, 
this residue was subjected to saturating mutagenesis. 
Preliminary results of ampicillin synthesis in diluted 
solutions showed that all 19 mutants have an increased 
ability to transfer an acyl group to 6-APA. Three of 
the most promising mutants of EcPA (αArg145Leu, 
αArg145Gly and αArg145Ser) were selected and sub-
jected to a detailed kinetic study (table 5).
The obtained results show that the removal of a pos-
itive charge in position α145 leads to a substantial in-
crease in the nucleophilic properties of 6-APA. A near-
ly synchronized increase in α leads to the conclusion 
that elevated nucleophile binding (Kn, see the scheme 
above), expressed as an increase in β, inevitably results 
in higher affinity to the reaction product (Kp, see the 
scheme above), and it is impossible to improve both pa-
rameters simultaneously. However, the negative ef-
fects on α can be mitigated to some extent if ampicillin 
is removed from the reaction medium.
According to X-ray diffraction data, the residue 
αPhe146 interacts with the methyl group of penicillin REVIEWS
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upon its binding in the open conformation and could af-
fect the binding of the β-lactam ring of 6-APA. In order 
to clarify the role of this residue, saturation mutation 
analysis was also carried out. Preliminary studies of en-
zymatic ampicillin synthesis showed that all 19 mutants 
have an increased ability to transfer the acyl group to 
6-APA, but the catalytic activity of all mutants decreas-
es at least 10-fold, which did not allow the authors to 
study the synthetic abilities of the mutants in detail.
Work [90] represents a good example of employing 
rational design for improving EcPA catalytic properties. 
The authors performed a structural analysis and molec-
ular modeling of ligand binding in the active site of the 
enzyme. The results showed that mutation of βPhe71 
alters the substrate’s orientation and increases the inter-
action of substrates with the oxianionic hole. Therefore, 
it would be reasonable to expect the mutation of βPhe71 
to increase the PA catalytic activity and alter both the 
stereoselectivity and specificity of the enzyme for the 
leaving group. Four mutants with amino acid changes   
βPhe71Lys, βPhe71Glu, βPhe71Leu, and βPhe71Arg 
were prepared. Three of them showed improved cata-
lytic properties, and two mutants had higher stereose-
lectivity in terms of separation of enantiomers; however, 
the effect of an introduction of a particular amino acid 
was quite opposite. For example, the βPhe71Leu mu-
tant had the best catalytic properties in the antibiot-
ics synthesis reactions, while its enentioselectivity was 
lower than that of the wild type enzyme. The most pro-
nounced increase in enantioselectivity was observed for 
the mutant EcPA βPhe71Lysones for the mutant EcPA 
βPhe71Leu. Based on the obtained data, one made the 
conclusion that a simultaneous improvement of all basic 
catalytic properties of the enzyme seems to be impos-
sible. Evidently, particular tasks could be solved only by 
individual fine-tuning of the enzyme based on the sub-
strate’s structure.
Obtaining a permutated enzyme
Another approach to alter the enzyme’s properties is 
preparation of so-called permutated enzymes. As seen 
in Figs. 4 and 5, in PAs from E. coli and A. faecalis, the 
N-terminus of the α-subunit is placed in juxtaposition 
with the C-terminus of the β-subunit, which allows to 
obtain a permutated one-chain enzyme by linking both 
termini by a flexible spacer. Engineering such an en-
zyme would allow to obtain the recombinant protein 
directly in the cytoplasm without transportation of the 
precursor to the periplasmic compartment and cleav-
age of the inter-subunit spacer, since these stages were 
shown to be the main reasons of the low yield of the 
enzyme produced in available systems of PA-G expres-
sion. To this day, there is only one work that describes 
preparation of the permutated enzyme [91]. A random 
sequence of 4 amino acid residues was chosen as a link-
er between the subunits. A library of mutant clones 
carrying the gene of the permutated enzyme was cre-
ated. Subsequent screening of the clones revealed 20 
clones that produced the active enzyme; however, all 
the mutants were much less efficient in terms of spe-
cific activity as compared to the wild type enzyme.
AfPA stabilization by formation of disulfide bonds
As it was described earlier, PA from A. faecalis is one 
of the most thermostable penicillin acyllases known to 
this day [20], and this remarkable property is attribut-
ed to the presence of a disulfide bond in the β-subunit 
of AfPA (Fig. 5). Additional disulfide bonds were intro-
duced into the enzyme’s globule in order to further sta-
bilize the molecule [92]. Since 2006, when the experi-
ments were performed, the structure of the enzyme 
has not been determined. The authors constructed a 
computer model using homology modeling based on 
the structure of EcPA. The search for possible sites 
of disulfide location was performed with the MODIP 
program. The computer analysis resulted in 32 possible 
variants of disulfide bonds in different positions. An ad-
ditional analysis yielded two final variants - pairs of 
substitutions αQ3C/βP561C and αT52C/αY64C. The 
first pair of substitutions should lead to the formation 
of the covalent bond between the N-terminus of the 
α-subunit and the C-terminus of the β-subunit (see in-
set in Fig. 5), which is basically unstructured (Fig. 5). In 
the case of the second pair of amino acid changes, the 
disulfide bond should stabilize a loop that connects two 
α-helices. The analysis of the properties of the obtained 
mutants showed that introduction of the point muta-
tions αGlu3Cys and βPro561Cys did not affect the rate 
of thermal inactivation, while in the case of the double 
substitution, the temperature at which the enzyme 
loses 50% of its activity after 20 minutes of incubation 
increased from 50oC to 53 oC. The second pair of sub-
stitutions did not affect the enzyme’s stability, which 
suggests that the stability of the two α-helices is not 
critical for the stability of the whole protein globule. 
This suggestion corroborates recent X-ray diffraction 
data, which show that the mentioned α-helices form 
additional contacts with the structural elements of the 
β-subunit.
CONCLUSIONS
Despite the large volume of work on the engineer -
ing of penicillin acylases, the problem of altering the 
catalytic properties and stability of PAs is far from be-
ing solved. The data presented show that the catalysis 
is affected by residues located at 15-20 Å around the 
catalytic site of the enzyme. Therefore, a detailed in-
vestigation of the roles of amino acid residues located 60 | ACTA NATURAE |  VOL. 2  № 3 (6)  2010
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in the active site in catalysis and substrate specificity, 
as well as gaining insight into how they affect catalytic 
parameters, appears to be important for both biotech-
nology and fundamental science. It’s one’s hope that 
isolation and investigation of penicillin acylases from 
other sources could reveal the basic principles of the 
“structure-function” relationship in this enzyme. 
The work was supported by the Russian Foundation 
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